Figure 5From: Employment of digital gene expression profiling to identify potential pathogenic and therapeutic targets of fulminant hepatic failure Validations of NF-κB and its regulated DEGs in FHF liver samples. (A) The expression of NF-κB and its negative regulator IκBα by Western blotting. (B) The mRNA levels of partial NF-κB regulated DEGs by qPCR.Back to article page